Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anne-Lise Børresen-Dale
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Concepts & Ideas
Devices
Procedures
Physiology
Chemicals & Drugs
Genes & Molecular Sequences
Geographic Areas
Sign-in to see full Profile
Network (preview)
37
Kristensen, Vessela
27
Lønning, Per Eystein
21
Sørlie, Therese
18
Nesland, Jahn
15
Helland, Aslaug
13
Langerød, Anita
13
Kåresen, Rolf
12
Kristensen, Gunnar
12
Perou, Charles
12
Holm, Ruth
11
Jeffrey, Stefanie
11
Johnsen, Hilde
10
Andersen, Tone Ikdal
9
Geisler, Stephanie
9
Olsen, Jørgen
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anne-Lise Børresen-Dale (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Landmark-Høyvik H; Reinertsen K V; Loge J H; Fosså S D; Børresen-Dale A L; Dumeaux V
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors.
The pharmacogenomics journal 2009;9(5):333-40.
-
2009: Lönneborg Anders; Aarøe Jørgen; Dumeaux Vanessa; Børresen-Dale Anne-Lise
Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Expert review of anticancer therapy 2009;9(8):1115-23.
-
2009: Kamalakaran Sitharthan; Kendall Jude; Zhao Xiaoyue; Tang Chunlao; Khan Sohail; Ravi Kandasamy; Auletta Theresa; Riggs Michael; Wang Yun; Helland Aslaug; Naume Bjørn; Dimitrova Nevenka; Børresen-Dale Anne-Lise; Hicks Jim; Lucito Robert
Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.
Nucleic acids research 2009;37(12):e89.
-
2009: Glynn Sharon A; Boersma Brenda J; Howe Tiffany M; Edvardsen Hege; Geisler Stephanie B; Goodman Julie E; Ridnour Lisa A; Lønning Per E; Børresen-Dale Anne-Lise; Naume Bjorn; Kristensen Vessela N; Chanock Stephen J; Wink David A; Ambs Stefan
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):4165-73.
-
2009: Murph Mandi M; Liu Wenbin; Yu Shuangxing; Lu Yiling; Hall Hassan; Hennessy Bryan T; Lahad John; Schaner Marci; Helland Aslaug; Kristensen Gunnar; Børresen-Dale Anne-Lise; Mills Gordon B
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PloS one 2009;4(5):e5583.
-
2008: Bergamaschi Anna; Kim Young H; Kwei Kevin A; La Choi Yoon; Bocanegra Melanie; Langerød Anita; Han Wonshik; Noh Dong-Young; Huntsman David G; Jeffrey Stefanie S; Børresen-Dale Anne-Lise; Pollack Jonathan R
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.
Molecular oncology 2008;2(4):327-39.
-
2008: Concannon Patrick; Haile Robert W; Børresen-Dale Anne-Lise; Rosenstein Barry S; Gatti Richard A; Teraoka Sharon N; Diep T Anh; Jansen Laila; Atencio David P; Langholz Bryan; Capanu Marinela; Liang Xiaolin; Begg Colin B; Thomas Duncan C; Bernstein Leslie; Olsen Jørgen H; Malone Kathleen E; Lynch Charles F; Anton-Culver Hoda; Bernstein Jonine L;
Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Cancer research 2008;68(16):6486-91.
-
2008: Nordgard Silje H; Alnaes Grethe I G; Hihn Björn; Lingjaerde Ole Christian; Liestøl Knut; Tsalenko Anya; Sørlie Therese; Lønning Per Eystein; Børresen-Dale Anne-Lise; Kristensen Vessela N
Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.
International journal of cancer. Journal international du cancer 2008;123(3):577-85.
-
2008: Nordgard Silje H; Johansen Fredrik E; Alnaes Grethe I G; Bucher Elmar; Syvänen Ann-Christine; Naume Bjørn; Børresen-Dale Anne-Lise; Kristensen Vessela N
Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients.
Genes, chromosomes & cancer 2008;47(8):680-96.
-
2008: Rønneberg Jo Anders; Tost Jörg; Solvang Hiroko K; Alnaes Grethe I G; Johansen Fredrik E; Brendeford Elen M; Yakhini Zohar; Gut Ivo G; Lønning Per Eystein; Børresen-Dale Anne-Lise; Gabrielsen Odd S; Kristensen Vessela N
GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
Cancer research 2008;68(14):5562-71.
-
2008: Suspitsin Evgeny N; Due Eldri U; Vu Phuong; Hirvonen Ari; Børresen-Dale Anne-Lise; Imyanitov Evgeny N
TP53 mutations in synchronous and metachronous bilateral breast carcinomas.
Cancer genetics and cytogenetics 2008;184(2):119-21.
-
2008: Horlings Hugo M; Bergamaschi Anna; Nordgard Silje H; Kim Young H; Han Wonshik; Noh Dong-Young; Salari Keyan; Joosse Simon A; Reyal Fabien; Lingjaerde Ole Christian; Kristensen Vessela N; Børresen-Dale Anne-Lise; Pollack Jonathan; van de Vijver Marc J
ESR1 gene amplification in breast cancer: a common phenomenon?
Nature genetics 2008;40(7):807-8; author reply 810-2.
-
2008: Kristensen Vessela N; Børresen-Dale Anne-Lise
SNPs associated with molecular subtypes of breast cancer: on the usefulness of stratified Genome-wide Association Studies (GWAS) in the identification of novel susceptibility loci.
Molecular oncology 2008;2(1):12-5.
-
2008: Rødningen Olaug Kristin; Børresen-Dale Anne-Lise; Alsner Jan; Hastie Trevor; Overgaard Jens
Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;86(3):314-20.
-
2008: Mellemkjaer L; Dahl C; Olsen J H; Bertelsen L; Guldberg P; Christensen J; Børresen-Dale A-L; Stovall M; Langholz B; Bernstein L; Lynch C F; Malone K E; Haile R W; Andersson M; Thomas D C; Concannon P; Capanu M; Boice J D; Bernstein J L
Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.
British journal of cancer 2008;98(4):728-33.
-
2008: Tongbai Ron; Idelman Gila; Nordgard Silje H; Cui Wenwu; Jacobs Jonathan L; Haggerty Cynthia M; Chanock Stephen J; Børresen-Dale Anne-Lise; Livingston Gary; Shaunessy Patrick; Chiang Chih-Hung; Kristensen Vessela N; Bilke Sven; Gardner Kevin
Transcriptional networks inferred from molecular signatures of breast cancer.
The American journal of pathology 2008;172(2):495-509.
-
2008: Bergamaschi A; Tagliabue E; Sørlie T; Naume B; Triulzi T; Orlandi R; Russnes H G; Nesland J M; Tammi R; Auvinen P; Kosma V-M; Ménard S; Børresen-Dale A-L
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
The Journal of pathology 2008;214(3):357-67.
-
2008: Roca Xavier; Olson Andrew J; Rao Atmakuri R; Enerly Espen; Kristensen Vessela N; Børresen-Dale Anne-Lise; Andresen Brage S; Krainer Adrian R; Sachidanandam Ravi
Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.
Genome research 2008;18(1):77-87.
-
2008: Brosh Ran; Shalgi Reut; Liran Atar; Landan Gilad; Korotayev Katya; Nguyen Giang Huong; Enerly Espen; Johnsen Hilde; Buganim Yosef; Solomon Hilla; Goldstein Ido; Madar Shalom; Goldfinger Naomi; Børresen-Dale Anne-Lise; Ginsberg Doron; Harris Curtis C; Pilpel Yitzhak; Oren Moshe; Rotter Varda
p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.
Molecular systems biology 2008;4():229.
-
2008: Baumbusch L O; Aarøe J; Johansen F E; Hicks J; Sun H; Bruhn L; Gunderson K; Naume B; Kristensen V N; Liestøl K; Børresen-Dale A-L; Lingjaerde O C
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.
BMC genomics 2008;9():379.
-
2008: Alsner Jan; Jensen Vibeke; Kyndi Marianne; Offersen Birgitte Vrou; Vu Phuong; Børresen-Dale Anne-Lise; Overgaard Jens
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Acta oncologica (Stockholm, Sweden) 2008;47(4):600-7.
-
2008: Dumeaux Vanessa; Børresen-Dale Anne-Lise; Frantzen Jan-Ole; Kumle Merethe; Kristensen Vessela N; Lund Eiliv
Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study.
Breast cancer research : BCR 2008;10(1):R13.
-
2007: Garcia-Closas Montserrat; Kristensen Vessela; Langerød Anita; Qi Ying; Yeager Meredith; Burdett Laurie; Welch Robert; Lissowska Jolanta; Peplonska Beata; Brinton Louise; Gerhard Daniela S; Gram Inger Torhild; Perou Charles M; Børresen-Dale Anne-Lise; Chanock Stephen
Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
International journal of cancer. Journal international du cancer 2007;121(11):2532-8.
-
2007: Casalini Patrizia; Iorio Marilena V; Berno Valeria; Bergamaschi Anna; Børresen Dale Anne-Lise; Gasparini Patrizia; Orlandi Rosaria; Casati Barbara; Tagliabue Elda; Ménard Sylvie
Relationship between p53 and p27 expression following HER2 signaling.
Breast (Edinburgh, Scotland) 2007;16(6):597-605.
-
2007: Garcia-Closas Montserrat; Troester Melissa A; Qi Ying; Langerød Anita; Yeager Meredith; Lissowska Jolanta; Brinton Louise; Welch Robert; Peplonska Beata; Gerhard Daniela S; Gram Inger Torhild; Kristensen Vessela; Børresen-Dale Anne-Lise; Chanock Stephen; Perou Charles M
Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(11):2269-75.
-
2007: Naume Bjørn; Zhao Xi; Synnestvedt Marit; Borgen Elin; Russnes Hege Giercksky; Lingjaerde Ole Christian; Strømberg Maria; Wiedswang Gro; Kvalheim Gunnar; Kåresen Rolf; Nesland Jahn M; Børresen-Dale Anne-Lise; Sørlie Therese
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.
Molecular oncology 2007;1(2):160-71.
-
2007: Knappskog Stian; Chrisanthar Ranjan; Staalesen Vidar; Børresen-Dale Anne-Lise; Gram Inger Torhild; Lillehaug Johan Richard; Lønning Per Eystein
Mutations and polymorphisms of the p21B transcript in breast cancer.
International journal of cancer. Journal international du cancer 2007;121(4):908-10.
-
2007: Landmark H; Nahas S A; Aarøe J; Gatti R; Børresen-Dale A-L; Rødningen O K
Transcriptional response to ionizing radiation in human radiation sensitive cell lines.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):256-60.
-
2007: Nicolau Monica; Tibshirani Robert; Børresen-Dale Anne-Lise; Jeffrey Stefanie S
Disease-specific genomic analysis: identifying the signature of pathologic biology.
Bioinformatics (Oxford, England) 2007;23(8):957-65.
-
2007: Størvold Gro Leite; Gjernes Elisabet; Askautrud Hanne Arenberg; Børresen-Dale Anne-Lise; Perou Charles M; Frengen Eirik
A retroviral vector for siRNA expression in mammalian cells.
Molecular biotechnology 2007;35(3):275-82.
-
2007: Edvardsen Hege; Kristensen Vessela N; Grenaker Alnaes Grethe Irene; Bøhn Mona; Erikstein Bjørn; Helland Aslaug; Børresen-Dale Anne-Lise; Fosså Sophie Dorothea
Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy.
International journal of radiation oncology, biology, physics 2007;67(4):1163-71.
-
2007: Irish Jonathan M; Anensen Nina; Hovland Randi; Skavland Jørn; Børresen-Dale Anne-Lise; Bruserud Oystein; Nolan Garry P; Gjertsen Bjørn T
Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
Blood 2007;109(6):2589-96.
-
2007: Nordgard Silje H; Ritchie Marylyn D; Jensrud Sigrid D; Motsinger Alison A; Alnaes Grethe I G; Lemmon Gordon; Berg Marianne; Geisler Stephanie; Moore Jason H; Lønning Per Eystein; Børresen-Dale Anne-Lise; Kristensen Vessela N
ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Pharmacogenetics and genomics 2007;17(2):127-36.
-
2007: Yosef Nir; Yakhini Zohar; Tsalenko Anya; Kristensen Vessela; Børresen-Dale Anne-Lise; Ruppin Eytan; Sharan Roded
A supervised approach for identifying discriminating genotype patterns and its application to breast cancer data.
Bioinformatics (Oxford, England) 2007;23(2):e91-8.
-
2007: Nordgard Silje H; Johansen Fredrik E; Alnaes Grethe I G; Naume Bjørn; Børresen-Dale Anne-Lise; Kristensen Vessela N
Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes.
Breast cancer research : BCR 2007;9(6):113.
-
2007: Edvardsen Hege; Tefre Toril; Jansen Laila; Vu Phuong; Haffty Bruce G; Fosså Sophie D; Kristensen Vessela N; Børresen-Dale Anne-Lise
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence.
Radiation oncology (London, England) 2007;2():25.
-
2007: Langerød Anita; Zhao Hongjuan; Borgan Ørnulf; Nesland Jahn M; Bukholm Ida R K; Ikdahl Tone; Kåresen Rolf; Børresen-Dale Anne-Lise; Jeffrey Stefanie S
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Breast cancer research : BCR 2007;9(3):R30.
-
2007: Chanock Stephen J; Burdett Laurie; Yeager Meredith; Llaca Victor; Langerød Anita; Presswalla Shafaq; Kaaresen Rolf; Strausberg Robert L; Gerhard Daniela S; Kristensen Vessela; Perou Charles M; Børresen-Dale Anne-Lise
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.
Breast cancer research : BCR 2007;9(1):R5.
-
2006: Hicks James; Krasnitz Alexander; Lakshmi B; Navin Nicholas E; Riggs Michael; Leibu Evan; Esposito Diane; Alexander Joan; Troge Jen; Grubor Vladimir; Yoon Seungtai; Wigler Michael; Ye Kenny; Børresen-Dale Anne-Lise; Naume Bjørn; Schlicting Ellen; Norton Larry; Hägerström Torsten; Skoog Lambert; Auer Gert; Månér Susanne; Lundin Pär; Zetterberg Anders
Novel patterns of genome rearrangement and their association with survival in breast cancer.
Genome research 2006;16(12):1465-79.
-
2006: Sørlie Therese; Perou Charles M; Fan Cheng; Geisler Stephanie; Aas Turid; Nobel Andrew; Anker Gun; Akslen Lars A; Botstein David; Børresen-Dale Anne-Lise; Lønning Per Eystein
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer.
Molecular cancer therapeutics 2006;5(11):2914-8.
-
2006: Bergamaschi Anna; Kim Young H; Wang Pei; Sørlie Therese; Hernandez-Boussard Tina; Lonning Per E; Tibshirani Robert; Børresen-Dale Anne-Lise; Pollack Jonathan R
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Genes, chromosomes & cancer 2006;45(11):1033-40.
-
2006: Staalesen Vidar; Knappskog Stian; Chrisanthar Ranjan; Nordgard Silje H; Løkkevik Erik; Anker Gun; Ostenstad Bjørn; Lundgren Steinar; Risberg Terje; Mjaaland Ingvil; Gram Inger Torhild; Kristensen Vessela N; Børresen-Dale Anne-Lise; Lillehaug Johan Richard; Lønning Per Eystein
The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 1):6000-4.
-
2006: Helland Aslaug; Johnsen Hilde; Frøyland Caroline; Landmark Hege B K; Saetersdal Anna B; Holmen Marit Muri; Gjertsen Turid; Nesland Jahn M; Ottestad William; Jeffrey Stefanie S; Ottestad Lars O; Rodningen Olag K; Sherlock Gavin; Børresen-Dale Anne-Lise
Radiation-induced effects on gene expression: an in vivo study on breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):230-5.
-
2006: Langholz Bryan; Bernstein Jonine L; Bernstein Leslie; Olsen Jørgen H; Børresen-Dale Anne-Lise; Rosenstein Barry S; Gatti Richard A; Concannon Patrick
On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer.
International journal of cancer. Journal international du cancer 2006;119(3):724-5.
-
2006: Heikkinen Katri; Rapakko Katrin; Karppinen Sanna-Maria; Erkko Hannele; Knuutila Sakari; Lundán Tuija; Mannermaa Arto; Børresen-Dale Anne-Lise; Borg Ake; Barkardottir Rosa B; Petrini John; Winqvist Robert
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
Carcinogenesis 2006;27(8):1593-9.
-
2006: Kristensen Vessela N; Edvardsen Hege; Tsalenko Anya; Nordgard Silje H; Sørlie Therese; Sharan Roded; Vailaya Aditya; Ben-Dor Amir; Lønning Per Eystein; Lien Sigbjørn; Omholt Stig; Syvänen Ann-Christine; Yakhini Zohar; Børresen-Dale Anne-Lise
Genetic variation in putative regulatory loci controlling gene expression in breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(20):7735-40.
-
2006: Tsalenko Anya; Sharan Roded; Kristensen Vessela; Edvardsen Hege; Børresen-Dale Anne-Lise; Ben-Dor Amir; Yakhini Zohar
Analysis of SNP-expression association matrices.
Journal of bioinformatics and computational biology 2006;4(2):259-74.
-
2006: Dumeaux Vanessa; Johansen Jostein; Børresen-Dale Anne-Lise; Lund Eiliv
Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy.
Molecular cancer therapeutics 2006;5(4):868-76.
-
2006: Lønning Per Eystein; Børresen-Dale Anne-Lise
Interaction between p53 staining and high-dose chemotherapy in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2289.
-
2006: Edvardsen Hege; Irene Grenaker Alnaes Grethe; Tsalenko Anya; Mulcahy Tanya; Yuryev Anton; Lindersson Marie; Lien Sigbjørn; Omholt Stig; Syvänen Ann-Christine; Børresen-Dale Anne-Lise; Kristensen Vessela N
Experimental validation of data mined single nucleotide polymorphisms from several databases and consecutive dbSNP builds.
Pharmacogenetics and genomics 2006;16(3):207-17.
-
2006: Chi Jen-Tsan; Wang Zhen; Nuyten Dimitry S A; Rodriguez Edwin H; Schaner Marci E; Salim Ali; Wang Yun; Kristensen Gunnar B; Helland Aslaug; Børresen-Dale Anne-Lise; Giaccia Amato; Longaker Michael T; Hastie Trevor; Yang George P; van de Vijver Marc J; Brown Patrick O
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.
PLoS medicine 2006;3(3):e47.
-
2006: Olivier Magali; Langerød Anita; Carrieri Patrizia; Bergh Jonas; Klaar Sigrid; Eyfjord Jorunn; Theillet Charles; Rodriguez Carmen; Lidereau Rosette; Bièche Ivan; Varley Jennifer; Bignon Yves; Uhrhammer Nancy; Winqvist Robert; Jukkola-Vuorinen Arja; Niederacher Dieter; Kato Shunsuke; Ishioka Chikashi; Hainaut Pierre; Børresen-Dale Anne-Lise
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1157-67.
-
2006: Tavtigian Sean V; Pierotti Marco A; Børresen-Dale Anne-Lise
International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'.
Breast cancer research : BCR 2006;8(6):303.
-
2006: Baumbusch Lars O; Myhre Simen; Langerød Anita; Bergamaschi Anna; Geisler Stephanie B; Lønning Per E; Deppert Wolfgang; Dornreiter Irene; Børresen-Dale Anne-Lise
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Molecular cancer 2006;5():47.
-
2006: Kapp Amy V; Jeffrey Stefanie S; Langerød Anita; Børresen-Dale Anne-Lise; Han Wonshik; Noh Dong-Young; Bukholm Ida R K; Nicolau Monica; Brown Patrick O; Tibshirani Robert
Discovery and validation of breast cancer subtypes.
BMC genomics 2006;7():231.
-
2006: Tommiska Johanna; Jansen Laila; Kilpivaara Outi; Edvardsen Hege; Kristensen Vessela; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Børresen-Dale Anne-Lise; Nevanlinna Heli
ATM variants and cancer risk in breast cancer patients from Southern Finland.
BMC cancer 2006;6():209.
-
2006: Sørlie Therese; Wang Yulei; Xiao Chunlin; Johnsen Hilde; Naume Bjørn; Samaha Raymond R; Børresen-Dale Anne-Lise
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
BMC genomics 2006;7():127.
-
2006: Muggerud Aslaug Aamodt; Johnsen Hilde; Barnes Debra A; Steel Adam; Lønning Per Eystein; Naume Bjørn; Sørlie Therese; Børresen-Dale Anne-Lise
Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes.
BMC cancer 2006;6():59.
-
2006: Kristensen Vessela N; Tsalenko Anya; Geisler Jurgen; Faldaas Anne; Grenaker Grethe Irene; Lingjaerde Ole Christian; Fjeldstad Ståle; Yakhini Zohar; Lønning Per Eystein; Børresen-Dale Anne-Lise
Multilocus analysis of SNP and metabolic data within a given pathway.
BMC genomics 2006;7():5.
-
2005: Rødningen Olaug Kristin; Overgaard Jens; Alsner Jan; Hastie Trevor; Børresen-Dale Anne-Lise
Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;77(3):231-40.
-
2005: Kringen Pedro; Bergamaschi Anna; Due Eldri Undlien; Wang Yun; Tagliabue Elda; Nesland Jahn M; Nehman Aune; Tönisson Neeme; Børresen-Dale Anne-Lise
Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas.
BioTechniques 2005;39(5):755-61.
-
2005: Maguire Paula; Margolin Sara; Skoglund Johanna; Sun Xiao-Feng; Gustafsson Jan-Ake; Børresen-Dale Anne-Lise; Lindblom Annika
Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer.
Breast cancer research and treatment 2005;94(2):145-52.
-
2005: Wang Yun; Kristensen Gunnar B; Helland Aslaug; Nesland Jahn M; Børresen-Dale Anne-Lise; Holm Ruth
Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.
American journal of clinical pathology 2005;124(3):392-401.
-
2005: Olsen J H; Hahnemann J M D; Børresen-Dale A-L; Tretli S; Kleinerman R; Sankila R; Hammarström L; Robsahm T E; Kääriäinen H; Bregård A; Brøndum-Nielsen K; Yuen J; Tucker M
Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.
British journal of cancer 2005;93(2):260-5.
-
2005: Kristensen Vessela Nedelcheva; Sørlie Therese; Geisler Jürgen; Yoshimura Noriko; Linegjaerde Ole-Christian; Glad Ingrid; Frigessi Arnoldo; Harada Nobuhiro; Lønning Per Eystein; Børresen-Dale Anne-Lise
Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer.
The Journal of steroid biochemistry and molecular biology 2005;95(1-5):105-11.
-
2005: Wang Yun; Helland Aslaug; Holm Ruth; Kristensen Gunnar B; Børresen-Dale Anne-Lise
PIK3CA mutations in advanced ovarian carcinomas.
Human mutation 2005;25(3):322.
-
2005: Aas Turid; Geisler Stephanie; Helle Hildegunn; Børresen-Dale Anne-Lise; Lønning Per Eystein; Akslen Lars Andreas
Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.
Oncology reports 2005;13(3):525-30.
-
2005: Benetkiewicz Magdalena; Wang Yun; Schaner Marci; Wang Pei; Mantripragada Kiran K; Buckley Patrick G; Kristensen Gunnar; Børresen-Dale Anne-Lise; Dumanski Jan P
High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
Genes, chromosomes & cancer 2005;42(3):228-37.
-
2005: Lingjaerde Ole Christian; Baumbusch Lars O; Liestøl Knut; Glad Ingrid K; Børresen-Dale Anne-Lise
CGH-Explorer: a program for analysis of array-CGH data.
Bioinformatics (Oxford, England) 2005;21(6):821-2.
-
2005: Lønning Per Eystein; Sørlie Therese; Børresen-Dale Anne-Lise
Genomics in breast cancer-therapeutic implications.
Nature clinical practice. Oncology 2005;2(1):26-33.
-
2005: Kristensen Vessela N; Sørlie Therese; Geisler Jurgen; Langerød Anita; Yoshimura Noriko; Kåresen Rolf; Harada Nobuhiro; Lønning P E; Børresen-Dale Anne-Lise
Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 2):878s-83s.
-
2005: Tsalenko Anya; Sharan Roded; Edvardsen Hege; Kristensen Vessela; Børresen-Dale Anne-Lise; Ben-Dor Amir; Yakhini Zohar
Analysis of SNP-expression association matrices.
Proceedings / IEEE Computational Systems Bioinformatics Conference, CSB. IEEE Computational Systems Bioinformatics Conference 2005;():135-43.
-
2005: Sharma Praveen; Sahni Narinder S; Tibshirani Robert; Skaane Per; Urdal Petter; Berghagen Hege; Jensen Marianne; Kristiansen Lena; Moen Cecilie; Sharma Pradeep; Zaka Alia; Arnes Jarle; Sauer Torill; Akslen Lars A; Schlichting Ellen; Børresen-Dale Anne-Lise; Lönneborg Anders
Early detection of breast cancer based on gene-expression patterns in peripheral blood cells.
Breast cancer research : BCR 2005;7(5):R634-44.
-
2005: Schaner Marci E; Davidson Ben; Skrede Martina; Reich Reuven; Flørenes Vivi Ann; Risberg Björn; Berner Aasmund; Goldberg Iris; Givant-Horwitz Vered; Tropè Claes G; Kristensen Gunnar B; Nesland Jahn M; Børresen-Dale Anne-Lise
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
Molecular cancer 2005;4():26.
-
2005: Sørlie Therese; Johnsen Hilde; Vu Phuong; Lind Guro Elisabeth; Lothe Ragnhild; Børresen-Dale Anne-Lise
Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis.
Methods in molecular biology (Clifton, N.J.) 2005;291():207-16.
-
2004: Staalesen Vidar; Falck Jacob; Geisler Stephanie; Bartkova Jirina; Børresen-Dale Anne-Lise; Lukas Jiri; Lillehaug Johan Richard; Bartek Jiri; Lønning Per Eystein
Alternative splicing and mutation status of CHEK2 in stage III breast cancer.
Oncogene 2004;23(52):8535-44.
-
2004: Usary Jerry; Llaca Victor; Karaca Gamze; Presswala Shafaq; Karaca Mehmet; He Xiaping; Langerød Anita; Kåresen Rolf; Oh Daniel S; Dressler Lynn G; Lønning Per E; Strausberg Robert L; Chanock Stephen; Børresen-Dale Anne-Lise; Perou Charles M
Mutation of GATA3 in human breast tumors.
Oncogene 2004;23(46):7669-78.
-
2004: Wang Yun; Kringen Pedro; Kristensen Gunnar B; Holm Ruth; Baekelandt Mark M O; Olivier Magali; Skomedal Hanne; Hainaut Pierre; Tropé Claes G; Abeler Vera M; Nesland Jahn M; Børresen-Dale Anne-Lise; Helland Aslaug
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Human mutation 2004;24(1):21-34.
-
2004: Troester Melissa A; Hoadley Katherine A; Sørlie Therese; Herbert Brittney-Shea; Børresen-Dale Anne-Lise; Lønning Per Eystein; Shay Jerry W; Kaufmann William K; Perou Charles M
Cell-type-specific responses to chemotherapeutics in breast cancer.
Cancer research 2004;64(12):4218-26.
-
2004: Zhao Hongjuan; Langerød Anita; Ji Youngran; Nowels Kent W; Nesland Jahn M; Tibshirani Rob; Bukholm Ida K; Kåresen Rolf; Botstein David; Børresen-Dale Anne-Lise; Jeffrey Stefanie S
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Molecular biology of the cell 2004;15(6):2523-36.
-
2004: Wang Y; Helland A; Holm R; Skomedal H; Abeler V M; Danielsen H E; Tropé C G; Børresen-Dale A-L; Kristensen G B
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.
British journal of cancer 2004;90(3):678-85.
-
2004: Bernstein Jonine L; Langholz Bryan; Haile Robert W; Bernstein Leslie; Thomas Duncan C; Stovall Marilyn; Malone Kathleen E; Lynch Charles F; Olsen Jørgen H; Anton-Culver Hoda; Shore Roy E; Boice John D; Berkowitz Gertrud S; Gatti Richard A; Teitelbaum Susan L; Smith Susan A; Rosenstein Barry S; Børresen-Dale Anne-Lise; Concannon Patrick; Thompson W Douglas;
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Breast cancer research : BCR 2004;6(3):R199-214.
-
2004: Yoshimura Noriko; Harada Nobuhiro; Bukholm Ida; Kåresen Rolf; Børresen-Dale Anne-Lise; Kristensen Vessela N
Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer.
Breast cancer research : BCR 2004;6(2):R46-55.
-
2003: Geisler Stephanie; Børresen-Dale Anne-Lise; Johnsen Hilde; Aas Turid; Geisler Jürgen; Akslen Lars Andreas; Anker Gun; Lønning Per Eystein
TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5582-8.
-
2003: Langerød Anita; Strømberg Maria; Chin Koei; Kristensen Vessela N; Børresen-Dale Anne-Lise
BUB1 infrequently mutated in human breast carcinomas.
Human mutation 2003;22(5):420.
-
2003: Bernstein J L; Bernstein L; Thompson W D; Lynch C F; Malone K E; Teitelbaum S L; Olsen J H; Anton-Culver H; Boice J D; Rosenstein B S; Børresen-Dale A-L; Gatti R A; Concannon P; Haile R W;
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.
British journal of cancer 2003;89(8):1513-6.
-
2003: Kristiansen Marianne; Helland Aslaug; Kristensen Gunnar B; Olsen Anne O; Lønning Per E; Børresen-Dale Anne Lise; Ørstavik Karen Helene
X chromosome inactivation in cervical cancer patients.
Cancer genetics and cytogenetics 2003;146(1):73-6.
-
2003: Sorlie Therese; Tibshirani Robert; Parker Joel; Hastie Trevor; Marron J S; Nobel Andrew; Deng Shibing; Johnsen Hilde; Pesich Robert; Geisler Stephanie; Demeter Janos; Perou Charles M; Lønning Per E; Brown Patrick O; Børresen-Dale Anne-Lise; Botstein David
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(14):8418-23.
-
2003: Soucek Pavel; Gut Ivan; Trneny Marek; Skovlund Eva; Grenaker Alnaes Grethe; Kristensen Tom; Børresen-Dale Anne-Lise; Kristensen Vessela N
Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin.
European journal of human genetics : EJHG 2003;11(5):416-9.
-
2003: Bernstein Jonine L; Teraoka Sharon; Haile Robert W; Børresen-Dale Anne-Lise; Rosenstein Barry S; Gatti Richard A; Diep Anh T; Jansen Laila; Atencio David P; Olsen Jørgen H; Bernstein Leslie; Teitelbaum Susan L; Thompson W Douglas; Concannon Patrick;
Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer.
Human mutation 2003;21(5):542-50.
-
2003: Pan-Hammarström Qiang; Dai Shujing; Zhao Yaofeng; van Dijk-Härd Iris F; Gatti Richard A; Børresen-Dale Anne-Lise; Hammarström Lennart
ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(7):3707-16.
-
2003: Aas T; Geisler S; Eide G E; Haugen D F; Varhaug J E; Bassøe A M; Thorsen T; Berntsen H; Børresen-Dale A L; Akslen L A; Lønning P E
Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy.
European journal of cancer (Oxford, England : 1990) 2003;39(4):438-46.
-
2003: Børresen-Dale Anne-Lise
TP53 and breast cancer.
Human mutation 2003;21(3):292-300.
-
2002: Langerød Anita; Bukholm Ida R K; Bregård André; Lønning Per Eystein; Andersen Tone Ikdal; Rognum Torleiv O; Meling Gunn Iren; Lothe Ragnhild A; Børresen-Dale Anne-Lise
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(12):1684-8.
-
2002: Kringen Pedro; Egedal Sidsel; Pedersen Jan C; Harbitz Thorstein B; Tveit Kjell M; Berg Kåre; Børresen-Dale Anne-Lise; Andersen Tone I
BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
Electrophoresis 2002;23(24):4085-91.
-
2002: Zhao Hongjuan; Hastie Trevor; Whitfield Michael L; Børresen-Dale Anne-Lise; Jeffrey Stefanie S
Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis.
BMC genomics 2002;3(1):31.
-
2002: Pollack Jonathan R; Sørlie Therese; Perou Charles M; Rees Christian A; Jeffrey Stefanie S; Lonning Per E; Tibshirani Robert; Botstein David; Børresen-Dale Anne-Lise; Brown Patrick O
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(20):12963-8.
-
2002: Passarino Giuseppe; Cavalleri Gianpiero L; Lin Alice A; Cavalli-Sforza Luigi Luca; Børresen-Dale Anne-Lise; Underhill Peter A
Different genetic components in the Norwegian population revealed by the analysis of mtDNA and Y chromosome polymorphisms.
European journal of human genetics : EJHG 2002;10(9):521-9.
-
2002: Jeffrey Stefanie S; Fero Michael J; Børresen-Dale Anne-Lise; Botstein David
Expression array technology in the diagnosis and treatment of breast cancer.
Molecular interventions 2002;2(2):101-9.
-
2002: Allinen M; Launonen V; Laake K; Jansen L; Huusko P; Kääriäinen H; Børresen-Dale A-L; Winqvist R
ATM mutations in Finnish breast cancer patients.
Journal of medical genetics 2002;39(3):192-6.
-
2002: Kristiansen M; Langerød A; Knudsen G P; Weber B L; Børresen-Dale A L; Orstavik K H
High frequency of skewed X inactivation in young breast cancer patients.
Journal of medical genetics 2002;39(1):30-3.
-
2002: Bernstein Jonine L; Seminara Daniela; Børresen-Dale Anne-Lise
Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002.
Breast cancer research : BCR 2002;4(6):249-52.
-
2001: Kristensen V N; Kure E H; Erikstein B; Harada N; Børresen-Dale A
Genetic susceptibility and environmental estrogen-like compounds.
Mutation research 2001;482(1-2):77-82.
-
2001: Forus A; Sørlie T; Børresen-Dale A L; Myklebost O
[Microarray technology--potential in cancer research]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(21):2498-503.
-
2001: Lønning P E; Sørlie T; Perou C M; Brown P O; Botstein D; Børresen-Dale A L
Microarrays in primary breast cancer--lessons from chemotherapy studies.
Endocrine-related cancer 2001;8(3):259-63.
-
2001: Sørlie T; Perou C M; Tibshirani R; Aas T; Geisler S; Johnsen H; Hastie T; Eisen M B; van de Rijn M; Jeffrey S S; Thorsen T; Quist H; Matese J C; Brown P O; Botstein D; Eystein Lønning P; Børresen-Dale A L
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(19):10869-74.
-
2001: Børresen-Dale A L; Hovig E; Smith-Sørensen B
Detection of mutations by denaturing gradient gel electrophoresis.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2001;Chapter 7():Unit 7.5.
-
2001: Bjørheim J; Ekstrøm P O; Fossberg E; Børresen-Dale A L; Gaudernack G
Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations.
BioTechniques 2001;30(5):972-5.
-
2001: Geisler S; Lønning P E; Aas T; Johnsen H; Fluge O; Haugen D F; Lillehaug J R; Akslen L A; Børresen-Dale A L
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
Cancer research 2001;61(6):2505-12.
-
2001: Kristensen V N; Børresen-Dale A L; Kristensen T
Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite ATAAA repeat.
Human mutation 2001;17(3):238-9.
-
2001: Kristensen V N; Kelefiotis D; Kristensen T; Børresen-Dale A L
High-throughput methods for detection of genetic variation.
BioTechniques 2001;30(2):318-22, 324, 326 passim.
-
2001: Olsen J H; Hahnemann J M; Børresen-Dale A L; Brøndum-Nielsen K; Hammarström L; Kleinerman R; Kääriäinen H; Lönnqvist T; Sankila R; Seersholm N; Tretli S; Yuen J; Boice J D; Tucker M
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
Journal of the National Cancer Institute 2001;93(2):121-7.
-
2001: Dai H; Holm R; Kristensen G B; Abeler V M; Børresen-Dale A L; Helland A
Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2001;23(2):45-9.
-
2001: Salahshor S; Haixin L; Huo H; Kristensen V N; Loman N; Sjöberg-Margolin S; Borg A; Børresen-Dale A L; Vorechovsky I; Lindblom A
Low frequency of E-cadherin alterations in familial breast cancer.
Breast cancer research : BCR 2001;3(3):199-207.
-
2000: Laake K; Vu P; Andersen T I; Erikstein B; Kåresen R; Lonning P E; Skovlund E; Børresen-Dale A L
Screening breast cancer patients for Norwegian ATM mutations.
British journal of cancer 2000;83(12):1650-3.
-
2000: Laake K; Jansen L; Hahnemann J M; Brondum-Nielsen K; Lönnqvist T; Kääriäinen H; Sankila R; Lähdesmäki A; Hammarström L; Yuen J; Tretli S; Heiberg A; Olsen J H; Tucker M; Kleinerman R; Børresen-Dale A L
Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia.
Human mutation 2000;16(3):232-46.
-
2000: Perou C M; Sørlie T; Eisen M B; van de Rijn M; Jeffrey S S; Rees C A; Pollack J R; Ross D T; Johnsen H; Akslen L A; Fluge O; Pergamenschikov A; Williams C; Zhu S X; Lønning P E; Børresen-Dale A L; Brown P O; Botstein D
Molecular portraits of human breast tumours.
Nature 2000;406(6797):747-52.
-
2000: Stokke T; Galteland E; Holte H; Smedshammer L; Suo Z; Smeland E B; Børresen-Dale A L; DeAngelis P; Steen H B
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 2000;89(4):313-24.
-
2000: Kristensen V N; Harada N; Yoshimura N; Haraldsen E; Lonning P E; Erikstein B; Kåresen R; Kristensen T; Børresen-Dale A L
Genetic variants of CYP19 (aromatase) and breast cancer risk.
Oncogene 2000;19(10):1329-33.
-
2000: Bukholm I K; Nesland J M; Børresen-Dale A L
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]
The Journal of pathology 2000;190(1):15-9.
-
2000: Jugessur A; Frost P; Andersen T I; Steine S; Lindblom A; Børresen-Dale A L; Eiken H G
Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism.
Journal of molecular medicine (Berlin, Germany) 2000;78(10):580-7.
-
1999: Helland A; Børresen-Dale A L
p53 polymorphism and cervical cancer.
Lancet 1999;354(9189):1561-2.
-
1999: Danielsen T; Smith-Sørensen B; Grønlund H A; Hvidsten M; Børresen-Dale A L; Rofstad E K
No association between radiosensitivity and TP53 status, G1 arrest or protein levels of p53, myc, ras or raf in human melanoma lines.
International journal of radiation biology 1999;75(9):1149-60.
-
1999: Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème M H; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen A M; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale A L
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1999;25(3):212-21.
-
1999: Nedelcheva Kristensen V; Haraldsen E K; Anderson K B; Lønning P E; Erikstein B; Kåresen R; Gabrielsen O S; Børresen-Dale A L
CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.
Cancer research 1999;59(12):2825-8.
-
1999: Skomedal H; Helland A; Kristensen G B; Holm R; Børresen-Dale A L
Allelic imbalance at chromosome region 11q23 in cervical carcinomas.
European journal of cancer (Oxford, England : 1990) 1999;35(4):659-63.
-
1999: Skomedal H; Kristensen G B; Nesland J M; Børresen-Dale A L; Tropé C; Holm R
TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
The Journal of pathology 1999;187(5):556-62.
-
1998: Helland A; Langerød A; Johnsen H; Olsen A O; Skovlund E; Børresen-Dale A L
p53 polymorphism and risk of cervical cancer.
Nature 1998;396(6711):530-1; author reply 532.
-
1998: Nedelcheva Kristensen V; Andersen T I; Erikstein B; Geitvik G; Skovlund E; Nesland J M; Børresen-Dale A L
Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.
Pharmacogenetics 1998;8(5):441-7.
-
1998: Bukholm I K; Berner J M; Nesland J M; Børresen-Dale A L
Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Virchows Archiv : an international journal of pathology 1998;433(3):223-8.
-
1998: Clausen O P; Lothe R A; Børresen-Dale A L; De Angelis P; Chen Y; Rognum T O; Meling G I
Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(4):215-23.
-
1998: Smith-Sørensen B; Kaern J; Holm R; Dørum A; Tropé C; Børresen-Dale A L
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.
British journal of cancer 1998;78(3):375-81.
-
1998: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen-Dale A L
E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
The Journal of pathology 1998;185(3):262-6.
-
1998: Bjørheim J; Lystad S; Lindblom A; Kressner U; Westring S; Wahlberg S; Lindmark G; Gaudernack G; Ekstrøm P; Røe J; Thilly W G; Børresen-Dale A L
Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.
Mutation research 1998;403(1-2):103-12.
-
1998: Lothe R A; Hektoen M; Johnsen H; Meling G I; Andersen T I; Rognum T O; Lindblom A; Børresen-Dale A L
The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer.
Cancer research 1998;58(14):2923-4.
-
1998: Helland A; Karlsen F; Due E U; Holm R; Kristensen G; Børresen-Dale A l
Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
British journal of cancer 1998;78(1):69-72.
-
1998: Laake K; Telatar M; Geitvik G A; Hansen R O; Heiberg A; Andresen A M; Gatti R; Børresen-Dale A L
Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect.
European journal of human genetics : EJHG 1998;6(3):235-44.
-
1998: Børresen-Dale A L; Boman H
[Hereditary cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(12):1873-7.
-
1998: Sørlie T; Martel-Planche G; Hainaut P; Lewalter J; Holm R; Børresen-Dale A L; Montesano R
Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.
British journal of cancer 1998;77(10):1573-9.
-
1998: Kristensen T; Kristensen V N; Børresen-Dale A L
High-throughput screening for known mutations by automated analysis of single sequencing reactions.
BioTechniques 1998;24(5):832-5.
-
1998: Eiken H G; Børresen-Dale A L
[Molecular genetic diagnostics. Technology for detecting mutations in DNA]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(11):1730-6.
-
1998: Børresen-Dale A L; Lothe R A; Nesland J M
[Molecular biology. Basis for increased understanding of diseases and improved diagnostics]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(11):1681.
-
1998: Sørlie T; Andersen T I; Bukholm I; Børresen-Dale A L
Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases.
Breast cancer research and treatment 1998;48(3):259-64.
-
1998: Kressner U; Bjørheim J; Westring S; Wahlberg S S; Påhlman L; Glimelius B; Lindmark G; Lindblom A; Børresen-Dale A L
Ki-ras mutations and prognosis in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(4):518-21.
-
1998: Helland A; Olsen A O; Gjøen K; Akselsen H E; Sauer T; Magnus P; Børresen-Dale A L; Rønningen K S
An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women.
International journal of cancer. Journal international du cancer 1998;76(1):19-24.
-
1998: Kristensen V N; Andersen T I; Lindblom A; Erikstein B; Magnus P; Børresen-Dale A L
A rare CYP19 (aromatase) variant may increase the risk of breast cancer.
Pharmacogenetics 1998;8(1):43-8.
-
1998: Børresen-Dale A L; Lothe R A; Meling G I; Hainaut P; Rognum T O; Skovlund E
TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):203-10.
-
1998: Sørlie T; Bukholm I; Børresen-Dale A L
Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas. Mutations in brief no. 179. Online.
Human mutation 1998;12(3):215.
-
1998: Andersen T I; Eiken H G; Couch F; Kaada G; Skrede M; Johnsen H; Aloysius T A; Tveit K M; Tranebjaerg L; Dørum A; Møller P; Weber B L; Børresen-Dale A L
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
Human mutation 1998;11(2):166-74.
-
1997: Breivik J; Lothe R A; Meling G I; Rognum T O; Børresen-Dale A L; Gaudernack G
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors.
International journal of cancer. Journal international du cancer 1997;74(6):664-9.
-
1997: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen-Dale A L
Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.
Virchows Archiv : an international journal of pathology 1997;431(5):317-21.
-
1997: Kristensen V N; Børresen-Dale A L
Improved electrophoretic separation of polymorphic short tandem repeats in agarose gels using bis-benzimide.
BioTechniques 1997;23(4):634-6.
-
1997: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen-Dale A L
Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53.
International journal of cancer. Journal international du cancer 1997;73(1):38-41.
-
1997: Laake K; Odegård A; Andersen T I; Bukholm I K; Kåresen R; Nesland J M; Ottestad L; Shiloh Y; Børresen-Dale A L
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Genes, chromosomes & cancer 1997;18(3):175-80.
-
1997: Helland A; Børresen-Dale A L; Peltomäki P; Hektoen M; Kristensen G B; Nesland J M; de la Chapelle A; Lothe R A
Microsatellite instability in cervical and endometrial carcinomas.
International journal of cancer. Journal international du cancer 1997;70(5):499-501.
-
1997: Skomedal H; Kristensen G B; Abeler V M; Børresen-Dale A L; Tropé C; Holm R
TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.
The Journal of pathology 1997;181(2):158-65.
-
1997: Kraggerud S M; Jacobsen K D; Berner A; Stokke T; Holm R; Smedshammer L; Børresen-Dale A L; Fosså S D
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer.
Pathology, research and practice 1997;193(7):471-8.
-
1997: Anderson T I; Wooster R; Laake K; Collins N; Warren W; Skrede M; Elles R; Tveit K M; Johnston S R; Dowsett M; Olsen A O; Møller P; Stratton M R; Børresen-Dale A L
Screening for ESR mutations in breast and ovarian cancer patients.
Human mutation 1997;9(6):531-6.
-
1997: Zelada-Hedman M; Børresen-Dale A L; Lindblom A
Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation.
Human mutation 1997;9(3):289.
Sign-in to see more
